Universitätsklinikum Mannheim

First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG (2025) Reinhard S, Utikal JS, Zaremba A, Lodde G, von Wasielewski I, Klespe KC, Meier F, et al. Journal article Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry (2025) Albrecht A, Taubmann J, Minopoulou I, Hatscher L, Kleinert S, Mühlensiepen F, Welcker M, et al. Journal article Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (Journal of Cancer Research and Clinical Oncology, (2025), 151, 1, (30), 10.1007/s00432-024-06063-z) (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article, Erratum RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial (2025) Villacampa G, Llop-Guevara A, Filmann N, Herencia-Ropero A, Fasching P, Karn T, Marmé F, et al. Journal article Bots in white coats: are large language models the future of patient education? A multicenter cross-sectional analysis (2025) Aghamaliyev U, Karimbayli J, Zamparas A, Bösch F, Thomas M, Schmidt T, Krautz C, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Low-dose Oral Misoprostol after Cervical Ripening with a Double-balloon Catheter: 25 µg or 50 µg? (2025) Kehl S, Karademir ZS, Weiss C, Titzmann A, Schneider M, Beckmann M, Bader S Journal article Novel, standardized sample collection from the brain-nose interface (2025) San Nicoló M, Mertzig S, Berghaus A, Peters O, Frölich L, Grimmer T, Wiltfang J, et al. Journal article Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”: [ESMO Open 9 (2024) 103703](S2059702924014728)(10.1016/j.esmoop.2024.103703) (2025) Hofheinz RD, Herrle F, Dechow T, von Weikersthal LF, Welslau M, Lettmaier S, Burkart C, et al. Journal article, Erratum S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion (2025) Groβ S, Bitzer M, Albert J, Blödt S, Boda-Heggemann J, Borucki K, Brunner T, et al. Journal article